Senior Scientist, Translational Research at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Experienced in oncology research
Highly motivated, engaged, and creative scientist
Ability to thrive in a highly matrixed organization
Expertise to advance programs from candidate optimization through IND enabling activities to Proof-of-Concept clinical trials
Capable of shaping and driving translational strategies for oncology assets

Responsibilities

Design and develop biomarker, pharmacodynamic, and target engagement assays to understand drug mechanism of action and response
Perform laboratory-based experiments and data analysis to support clinical oncology studies, using various in vitro oncology and cancer immunology models and assays
Interact with project teams and contract laboratories for the design, execution, and oversight of molecular, cellular, and/or in vivo studies
Collaborate with cross-functional teams and external partners (CROs, specialty labs) to generate high-quality biomarker data for clinical studies
Contribute to translational plans, sample collection strategies, and documentation for early-phase trials
Present experimental results and share scientific insights with project teams and stakeholders
Proactively provide insight into novel ways to incorporate biomarkers

Skills

Oncology

Translational Research

Immuno-oncology

Cancer Biology

Cell Therapy

Drug Discovery

Biomarkers

In Vivo Models

In Vitro Models

Ex Vivo Models

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free